nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP2C8—Ifosfamide—testicular cancer	0.161	0.244	CbGbCtD
Sulfadiazine—CYP2C9—Ifosfamide—testicular cancer	0.112	0.17	CbGbCtD
Sulfadiazine—CYP2E1—Etoposide—testicular cancer	0.103	0.156	CbGbCtD
Sulfadiazine—CYP2C8—Etoposide—testicular cancer	0.0771	0.117	CbGbCtD
Sulfadiazine—CYP3A4—Ifosfamide—testicular cancer	0.0654	0.0989	CbGbCtD
Sulfadiazine—CYP2C9—Cisplatin—testicular cancer	0.0547	0.0827	CbGbCtD
Sulfadiazine—CYP3A4—Vinblastine—testicular cancer	0.0347	0.0525	CbGbCtD
Sulfadiazine—CYP3A4—Etoposide—testicular cancer	0.0312	0.0473	CbGbCtD
Sulfadiazine—CYP3A4—Doxorubicin—testicular cancer	0.0213	0.0322	CbGbCtD
Sulfadiazine—Anorexia—Chlorambucil—testicular cancer	0.00108	0.00319	CcSEcCtD
Sulfadiazine—Oliguria—Methotrexate—testicular cancer	0.00108	0.00318	CcSEcCtD
Sulfadiazine—Hepatitis—Ifosfamide—testicular cancer	0.00105	0.00311	CcSEcCtD
Sulfadiazine—Hallucination—Ifosfamide—testicular cancer	0.00105	0.0031	CcSEcCtD
Sulfadiazine—Chills—Dactinomycin—testicular cancer	0.00103	0.00305	CcSEcCtD
Sulfadiazine—Blood disorder—Doxorubicin—testicular cancer	0.00103	0.00304	CcSEcCtD
Sulfadiazine—Skin discolouration—Epirubicin—testicular cancer	0.00103	0.00304	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Vinblastine—testicular cancer	0.00102	0.003	CcSEcCtD
Sulfadiazine—Oliguria—Epirubicin—testicular cancer	0.00101	0.00298	CcSEcCtD
Sulfadiazine—Erythema multiforme—Ifosfamide—testicular cancer	0.000997	0.00294	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Cisplatin—testicular cancer	0.000993	0.00293	CcSEcCtD
Sulfadiazine—Anorexia—Vinblastine—testicular cancer	0.00099	0.00292	CcSEcCtD
Sulfadiazine—Stomatitis—Cisplatin—testicular cancer	0.000987	0.00291	CcSEcCtD
Sulfadiazine—Decreased appetite—Chlorambucil—testicular cancer	0.000985	0.00291	CcSEcCtD
Sulfadiazine—Tinnitus—Ifosfamide—testicular cancer	0.000983	0.0029	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.000978	0.00289	CcSEcCtD
Sulfadiazine—Leukopenia—Bleomycin—testicular cancer	0.000962	0.00284	CcSEcCtD
Sulfadiazine—Skin discolouration—Doxorubicin—testicular cancer	0.000953	0.00281	CcSEcCtD
Sulfadiazine—Skin exfoliation—Methotrexate—testicular cancer	0.000949	0.0028	CcSEcCtD
Sulfadiazine—Chills—Ifosfamide—testicular cancer	0.000946	0.00279	CcSEcCtD
Sulfadiazine—Oliguria—Doxorubicin—testicular cancer	0.000934	0.00276	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Methotrexate—testicular cancer	0.000933	0.00275	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Chlorambucil—testicular cancer	0.000926	0.00273	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Etoposide—testicular cancer	0.00092	0.00272	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Etoposide—testicular cancer	0.00091	0.00268	CcSEcCtD
Sulfadiazine—Stomatitis—Etoposide—testicular cancer	0.000905	0.00267	CcSEcCtD
Sulfadiazine—Decreased appetite—Vinblastine—testicular cancer	0.000902	0.00266	CcSEcCtD
Sulfadiazine—Urticaria—Chlorambucil—testicular cancer	0.0009	0.00266	CcSEcCtD
Sulfadiazine—Leukopenia—Dactinomycin—testicular cancer	0.000897	0.00265	CcSEcCtD
Sulfadiazine—Abdominal pain—Chlorambucil—testicular cancer	0.000896	0.00264	CcSEcCtD
Sulfadiazine—Body temperature increased—Chlorambucil—testicular cancer	0.000896	0.00264	CcSEcCtD
Sulfadiazine—Skin exfoliation—Epirubicin—testicular cancer	0.000888	0.00262	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Bleomycin—testicular cancer	0.000877	0.00259	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Epirubicin—testicular cancer	0.000873	0.00258	CcSEcCtD
Sulfadiazine—Agranulocytosis—Etoposide—testicular cancer	0.000866	0.00256	CcSEcCtD
Sulfadiazine—Sepsis—Methotrexate—testicular cancer	0.000862	0.00255	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Bleomycin—testicular cancer	0.000858	0.00253	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Vinblastine—testicular cancer	0.000849	0.00251	CcSEcCtD
Sulfadiazine—Tinnitus—Cisplatin—testicular cancer	0.000848	0.0025	CcSEcCtD
Sulfadiazine—Anorexia—Bleomycin—testicular cancer	0.000836	0.00247	CcSEcCtD
Sulfadiazine—Hypersensitivity—Chlorambucil—testicular cancer	0.000835	0.00246	CcSEcCtD
Sulfadiazine—Vertigo—Ifosfamide—testicular cancer	0.000825	0.00243	CcSEcCtD
Sulfadiazine—Leukopenia—Ifosfamide—testicular cancer	0.000822	0.00243	CcSEcCtD
Sulfadiazine—Polyuria—Methotrexate—testicular cancer	0.000821	0.00242	CcSEcCtD
Sulfadiazine—Skin exfoliation—Doxorubicin—testicular cancer	0.000821	0.00242	CcSEcCtD
Sulfadiazine—Abdominal pain—Vinblastine—testicular cancer	0.000821	0.00242	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Doxorubicin—testicular cancer	0.000808	0.00238	CcSEcCtD
Sulfadiazine—Sepsis—Epirubicin—testicular cancer	0.000807	0.00238	CcSEcCtD
Sulfadiazine—Pruritus—Chlorambucil—testicular cancer	0.000801	0.00237	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Dactinomycin—testicular cancer	0.000801	0.00236	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000799	0.00236	CcSEcCtD
Sulfadiazine—Convulsion—Ifosfamide—testicular cancer	0.000796	0.00235	CcSEcCtD
Sulfadiazine—Erythema multiforme—Etoposide—testicular cancer	0.000788	0.00232	CcSEcCtD
Sulfadiazine—Arthralgia—Ifosfamide—testicular cancer	0.000782	0.00231	CcSEcCtD
Sulfadiazine—Anorexia—Dactinomycin—testicular cancer	0.000779	0.0023	CcSEcCtD
Sulfadiazine—Diarrhoea—Chlorambucil—testicular cancer	0.000775	0.00229	CcSEcCtD
Sulfadiazine—Hypersensitivity—Vinblastine—testicular cancer	0.000765	0.00226	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Methotrexate—testicular cancer	0.000764	0.00226	CcSEcCtD
Sulfadiazine—Decreased appetite—Bleomycin—testicular cancer	0.000762	0.00225	CcSEcCtD
Sulfadiazine—Vascular purpura—Epirubicin—testicular cancer	0.000755	0.00223	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Ifosfamide—testicular cancer	0.000749	0.00221	CcSEcCtD
Sulfadiazine—Chills—Etoposide—testicular cancer	0.000747	0.00221	CcSEcCtD
Sulfadiazine—Sepsis—Doxorubicin—testicular cancer	0.000747	0.0022	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Methotrexate—testicular cancer	0.000745	0.0022	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000745	0.0022	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Ifosfamide—testicular cancer	0.000734	0.00217	CcSEcCtD
Sulfadiazine—Vomiting—Chlorambucil—testicular cancer	0.00072	0.00213	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Epirubicin—testicular cancer	0.000715	0.00211	CcSEcCtD
Sulfadiazine—Anorexia—Ifosfamide—testicular cancer	0.000714	0.00211	CcSEcCtD
Sulfadiazine—Decreased appetite—Dactinomycin—testicular cancer	0.000711	0.0021	CcSEcCtD
Sulfadiazine—Diarrhoea—Vinblastine—testicular cancer	0.00071	0.0021	CcSEcCtD
Sulfadiazine—Leukopenia—Cisplatin—testicular cancer	0.000709	0.00209	CcSEcCtD
Sulfadiazine—Purpura—Epirubicin—testicular cancer	0.0007	0.00207	CcSEcCtD
Sulfadiazine—Vascular purpura—Doxorubicin—testicular cancer	0.000698	0.00206	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Epirubicin—testicular cancer	0.000697	0.00206	CcSEcCtD
Sulfadiazine—Urticaria—Bleomycin—testicular cancer	0.000697	0.00206	CcSEcCtD
Sulfadiazine—Body temperature increased—Bleomycin—testicular cancer	0.000693	0.00205	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Epirubicin—testicular cancer	0.000692	0.00204	CcSEcCtD
Sulfadiazine—Convulsion—Cisplatin—testicular cancer	0.000686	0.00202	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000683	0.00202	CcSEcCtD
Sulfadiazine—Ataxia—Methotrexate—testicular cancer	0.000678	0.002	CcSEcCtD
Sulfadiazine—Nausea—Chlorambucil—testicular cancer	0.000673	0.00199	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000669	0.00197	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.000662	0.00195	CcSEcCtD
Sulfadiazine—Vomiting—Vinblastine—testicular cancer	0.00066	0.00195	CcSEcCtD
Sulfadiazine—Vertigo—Etoposide—testicular cancer	0.000652	0.00192	CcSEcCtD
Sulfadiazine—Decreased appetite—Ifosfamide—testicular cancer	0.000651	0.00192	CcSEcCtD
Sulfadiazine—Headache—Vinblastine—testicular cancer	0.00065	0.00192	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.000649	0.00192	CcSEcCtD
Sulfadiazine—Leukopenia—Etoposide—testicular cancer	0.000649	0.00192	CcSEcCtD
Sulfadiazine—Purpura—Doxorubicin—testicular cancer	0.000648	0.00191	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000647	0.00191	CcSEcCtD
Sulfadiazine—Body temperature increased—Dactinomycin—testicular cancer	0.000646	0.00191	CcSEcCtD
Sulfadiazine—Abdominal pain—Dactinomycin—testicular cancer	0.000646	0.00191	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Cisplatin—testicular cancer	0.000646	0.00191	CcSEcCtD
Sulfadiazine—Hypersensitivity—Bleomycin—testicular cancer	0.000646	0.00191	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.000645	0.0019	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Doxorubicin—testicular cancer	0.00064	0.00189	CcSEcCtD
Sulfadiazine—Ataxia—Epirubicin—testicular cancer	0.000635	0.00187	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Cisplatin—testicular cancer	0.000633	0.00187	CcSEcCtD
Sulfadiazine—Convulsion—Etoposide—testicular cancer	0.000628	0.00185	CcSEcCtD
Sulfadiazine—Pruritus—Bleomycin—testicular cancer	0.00062	0.00183	CcSEcCtD
Sulfadiazine—Nausea—Vinblastine—testicular cancer	0.000617	0.00182	CcSEcCtD
Sulfadiazine—Anorexia—Cisplatin—testicular cancer	0.000616	0.00182	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000613	0.00181	CcSEcCtD
Sulfadiazine—Pancreatitis—Methotrexate—testicular cancer	0.000611	0.0018	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.000608	0.00179	CcSEcCtD
Sulfadiazine—Hypersensitivity—Dactinomycin—testicular cancer	0.000602	0.00178	CcSEcCtD
Sulfadiazine—Urticaria—Ifosfamide—testicular cancer	0.000595	0.00176	CcSEcCtD
Sulfadiazine—Abdominal pain—Ifosfamide—testicular cancer	0.000592	0.00175	CcSEcCtD
Sulfadiazine—Body temperature increased—Ifosfamide—testicular cancer	0.000592	0.00175	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Etoposide—testicular cancer	0.000592	0.00175	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000589	0.00174	CcSEcCtD
Sulfadiazine—Ataxia—Doxorubicin—testicular cancer	0.000587	0.00173	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Etoposide—testicular cancer	0.000579	0.00171	CcSEcCtD
Sulfadiazine—Pancreatitis—Epirubicin—testicular cancer	0.000572	0.00169	CcSEcCtD
Sulfadiazine—Anorexia—Etoposide—testicular cancer	0.000564	0.00167	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000562	0.00166	CcSEcCtD
Sulfadiazine—Decreased appetite—Cisplatin—testicular cancer	0.000562	0.00166	CcSEcCtD
Sulfadiazine—Diarrhoea—Dactinomycin—testicular cancer	0.000559	0.00165	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000558	0.00165	CcSEcCtD
Sulfadiazine—Vomiting—Bleomycin—testicular cancer	0.000557	0.00165	CcSEcCtD
Sulfadiazine—Depression—Methotrexate—testicular cancer	0.000554	0.00164	CcSEcCtD
Sulfadiazine—Rash—Bleomycin—testicular cancer	0.000553	0.00163	CcSEcCtD
Sulfadiazine—Dermatitis—Bleomycin—testicular cancer	0.000552	0.00163	CcSEcCtD
Sulfadiazine—Hypersensitivity—Ifosfamide—testicular cancer	0.000552	0.00163	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000551	0.00163	CcSEcCtD
Sulfadiazine—Stomatitis—Methotrexate—testicular cancer	0.000542	0.0016	CcSEcCtD
Sulfadiazine—Pruritus—Ifosfamide—testicular cancer	0.00053	0.00156	CcSEcCtD
Sulfadiazine—Pancreatitis—Doxorubicin—testicular cancer	0.000529	0.00156	CcSEcCtD
Sulfadiazine—Nausea—Bleomycin—testicular cancer	0.000521	0.00154	CcSEcCtD
Sulfadiazine—Vomiting—Dactinomycin—testicular cancer	0.00052	0.00153	CcSEcCtD
Sulfadiazine—Agranulocytosis—Methotrexate—testicular cancer	0.000519	0.00153	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000516	0.00152	CcSEcCtD
Sulfadiazine—Rash—Dactinomycin—testicular cancer	0.000516	0.00152	CcSEcCtD
Sulfadiazine—Decreased appetite—Etoposide—testicular cancer	0.000514	0.00152	CcSEcCtD
Sulfadiazine—Diarrhoea—Ifosfamide—testicular cancer	0.000513	0.00151	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Etoposide—testicular cancer	0.000511	0.00151	CcSEcCtD
Sulfadiazine—Body temperature increased—Cisplatin—testicular cancer	0.000511	0.00151	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Epirubicin—testicular cancer	0.00051	0.00151	CcSEcCtD
Sulfadiazine—Stomatitis—Epirubicin—testicular cancer	0.000507	0.0015	CcSEcCtD
Sulfadiazine—Hepatitis—Methotrexate—testicular cancer	0.000499	0.00147	CcSEcCtD
Sulfadiazine—Nausea—Dactinomycin—testicular cancer	0.000486	0.00143	CcSEcCtD
Sulfadiazine—Agranulocytosis—Epirubicin—testicular cancer	0.000485	0.00143	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Etoposide—testicular cancer	0.000484	0.00143	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000477	0.00141	CcSEcCtD
Sulfadiazine—Vomiting—Ifosfamide—testicular cancer	0.000476	0.00141	CcSEcCtD
Sulfadiazine—Hypersensitivity—Cisplatin—testicular cancer	0.000476	0.0014	CcSEcCtD
Sulfadiazine—Rash—Ifosfamide—testicular cancer	0.000472	0.00139	CcSEcCtD
Sulfadiazine—Dermatitis—Ifosfamide—testicular cancer	0.000472	0.00139	CcSEcCtD
Sulfadiazine—Erythema multiforme—Methotrexate—testicular cancer	0.000472	0.00139	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000472	0.00139	CcSEcCtD
Sulfadiazine—Urticaria—Etoposide—testicular cancer	0.00047	0.00139	CcSEcCtD
Sulfadiazine—Stomatitis—Doxorubicin—testicular cancer	0.000469	0.00138	CcSEcCtD
Sulfadiazine—Abdominal pain—Etoposide—testicular cancer	0.000468	0.00138	CcSEcCtD
Sulfadiazine—Body temperature increased—Etoposide—testicular cancer	0.000468	0.00138	CcSEcCtD
Sulfadiazine—Hepatitis—Epirubicin—testicular cancer	0.000467	0.00138	CcSEcCtD
Sulfadiazine—Tinnitus—Methotrexate—testicular cancer	0.000465	0.00137	CcSEcCtD
Sulfadiazine—Agranulocytosis—Doxorubicin—testicular cancer	0.000449	0.00133	CcSEcCtD
Sulfadiazine—Chills—Methotrexate—testicular cancer	0.000448	0.00132	CcSEcCtD
Sulfadiazine—Nausea—Ifosfamide—testicular cancer	0.000445	0.00131	CcSEcCtD
Sulfadiazine—Diarrhoea—Cisplatin—testicular cancer	0.000442	0.0013	CcSEcCtD
Sulfadiazine—Erythema multiforme—Epirubicin—testicular cancer	0.000442	0.0013	CcSEcCtD
Sulfadiazine—Hypersensitivity—Etoposide—testicular cancer	0.000436	0.00129	CcSEcCtD
Sulfadiazine—Tinnitus—Epirubicin—testicular cancer	0.000435	0.00129	CcSEcCtD
Sulfadiazine—Hepatitis—Doxorubicin—testicular cancer	0.000432	0.00128	CcSEcCtD
Sulfadiazine—Chills—Epirubicin—testicular cancer	0.000419	0.00124	CcSEcCtD
Sulfadiazine—Pruritus—Etoposide—testicular cancer	0.000419	0.00124	CcSEcCtD
Sulfadiazine—Vomiting—Cisplatin—testicular cancer	0.000411	0.00121	CcSEcCtD
Sulfadiazine—Erythema multiforme—Doxorubicin—testicular cancer	0.000409	0.00121	CcSEcCtD
Sulfadiazine—Rash—Cisplatin—testicular cancer	0.000407	0.0012	CcSEcCtD
Sulfadiazine—Dermatitis—Cisplatin—testicular cancer	0.000407	0.0012	CcSEcCtD
Sulfadiazine—Diarrhoea—Etoposide—testicular cancer	0.000405	0.0012	CcSEcCtD
Sulfadiazine—Tinnitus—Doxorubicin—testicular cancer	0.000403	0.00119	CcSEcCtD
Sulfadiazine—Vertigo—Methotrexate—testicular cancer	0.00039	0.00115	CcSEcCtD
Sulfadiazine—Leukopenia—Methotrexate—testicular cancer	0.000389	0.00115	CcSEcCtD
Sulfadiazine—Chills—Doxorubicin—testicular cancer	0.000388	0.00114	CcSEcCtD
Sulfadiazine—Nausea—Cisplatin—testicular cancer	0.000384	0.00113	CcSEcCtD
Sulfadiazine—Convulsion—Methotrexate—testicular cancer	0.000376	0.00111	CcSEcCtD
Sulfadiazine—Vomiting—Etoposide—testicular cancer	0.000376	0.00111	CcSEcCtD
Sulfadiazine—Rash—Etoposide—testicular cancer	0.000373	0.0011	CcSEcCtD
Sulfadiazine—Dermatitis—Etoposide—testicular cancer	0.000373	0.0011	CcSEcCtD
Sulfadiazine—Headache—Etoposide—testicular cancer	0.000371	0.00109	CcSEcCtD
Sulfadiazine—Arthralgia—Methotrexate—testicular cancer	0.00037	0.00109	CcSEcCtD
Sulfadiazine—Vertigo—Epirubicin—testicular cancer	0.000365	0.00108	CcSEcCtD
Sulfadiazine—Leukopenia—Epirubicin—testicular cancer	0.000364	0.00107	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Methotrexate—testicular cancer	0.000354	0.00105	CcSEcCtD
Sulfadiazine—Convulsion—Epirubicin—testicular cancer	0.000352	0.00104	CcSEcCtD
Sulfadiazine—Nausea—Etoposide—testicular cancer	0.000352	0.00104	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Methotrexate—testicular cancer	0.000347	0.00102	CcSEcCtD
Sulfadiazine—Arthralgia—Epirubicin—testicular cancer	0.000346	0.00102	CcSEcCtD
Sulfadiazine—Vertigo—Doxorubicin—testicular cancer	0.000338	0.000997	CcSEcCtD
Sulfadiazine—Anorexia—Methotrexate—testicular cancer	0.000338	0.000997	CcSEcCtD
Sulfadiazine—Leukopenia—Doxorubicin—testicular cancer	0.000337	0.000994	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Epirubicin—testicular cancer	0.000332	0.000979	CcSEcCtD
Sulfadiazine—Convulsion—Doxorubicin—testicular cancer	0.000326	0.000962	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Epirubicin—testicular cancer	0.000325	0.000959	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000323	0.000953	CcSEcCtD
Sulfadiazine—Insomnia—Methotrexate—testicular cancer	0.000321	0.000946	CcSEcCtD
Sulfadiazine—Arthralgia—Doxorubicin—testicular cancer	0.00032	0.000945	CcSEcCtD
Sulfadiazine—Anorexia—Epirubicin—testicular cancer	0.000316	0.000933	CcSEcCtD
Sulfadiazine—Decreased appetite—Methotrexate—testicular cancer	0.000308	0.00091	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000307	0.000906	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000306	0.000903	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000302	0.000892	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000301	0.000887	CcSEcCtD
Sulfadiazine—Insomnia—Epirubicin—testicular cancer	0.0003	0.000886	CcSEcCtD
Sulfadiazine—Anorexia—Doxorubicin—testicular cancer	0.000293	0.000864	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Methotrexate—testicular cancer	0.00029	0.000856	CcSEcCtD
Sulfadiazine—Decreased appetite—Epirubicin—testicular cancer	0.000288	0.000851	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000286	0.000845	CcSEcCtD
Sulfadiazine—Urticaria—Methotrexate—testicular cancer	0.000282	0.000831	CcSEcCtD
Sulfadiazine—Abdominal pain—Methotrexate—testicular cancer	0.00028	0.000827	CcSEcCtD
Sulfadiazine—Body temperature increased—Methotrexate—testicular cancer	0.00028	0.000827	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.00028	0.000826	CcSEcCtD
Sulfadiazine—Insomnia—Doxorubicin—testicular cancer	0.000278	0.00082	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000271	0.000801	CcSEcCtD
Sulfadiazine—Decreased appetite—Doxorubicin—testicular cancer	0.000267	0.000788	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000265	0.000782	CcSEcCtD
Sulfadiazine—Urticaria—Epirubicin—testicular cancer	0.000264	0.000778	CcSEcCtD
Sulfadiazine—Abdominal pain—Epirubicin—testicular cancer	0.000262	0.000774	CcSEcCtD
Sulfadiazine—Body temperature increased—Epirubicin—testicular cancer	0.000262	0.000774	CcSEcCtD
Sulfadiazine—Hypersensitivity—Methotrexate—testicular cancer	0.000261	0.000771	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000251	0.000741	CcSEcCtD
Sulfadiazine—Pruritus—Methotrexate—testicular cancer	0.000251	0.00074	CcSEcCtD
Sulfadiazine—Hypersensitivity—Epirubicin—testicular cancer	0.000244	0.000721	CcSEcCtD
Sulfadiazine—Urticaria—Doxorubicin—testicular cancer	0.000244	0.00072	CcSEcCtD
Sulfadiazine—Abdominal pain—Doxorubicin—testicular cancer	0.000243	0.000716	CcSEcCtD
Sulfadiazine—Body temperature increased—Doxorubicin—testicular cancer	0.000243	0.000716	CcSEcCtD
Sulfadiazine—Diarrhoea—Methotrexate—testicular cancer	0.000243	0.000716	CcSEcCtD
Sulfadiazine—Pruritus—Epirubicin—testicular cancer	0.000235	0.000693	CcSEcCtD
Sulfadiazine—Diarrhoea—Epirubicin—testicular cancer	0.000227	0.00067	CcSEcCtD
Sulfadiazine—Hypersensitivity—Doxorubicin—testicular cancer	0.000226	0.000668	CcSEcCtD
Sulfadiazine—Vomiting—Methotrexate—testicular cancer	0.000225	0.000665	CcSEcCtD
Sulfadiazine—Rash—Methotrexate—testicular cancer	0.000224	0.00066	CcSEcCtD
Sulfadiazine—Dermatitis—Methotrexate—testicular cancer	0.000223	0.000659	CcSEcCtD
Sulfadiazine—Headache—Methotrexate—testicular cancer	0.000222	0.000656	CcSEcCtD
Sulfadiazine—Pruritus—Doxorubicin—testicular cancer	0.000217	0.000641	CcSEcCtD
Sulfadiazine—Vomiting—Epirubicin—testicular cancer	0.000211	0.000623	CcSEcCtD
Sulfadiazine—Nausea—Methotrexate—testicular cancer	0.000211	0.000622	CcSEcCtD
Sulfadiazine—Diarrhoea—Doxorubicin—testicular cancer	0.00021	0.00062	CcSEcCtD
Sulfadiazine—Rash—Epirubicin—testicular cancer	0.000209	0.000617	CcSEcCtD
Sulfadiazine—Dermatitis—Epirubicin—testicular cancer	0.000209	0.000617	CcSEcCtD
Sulfadiazine—Headache—Epirubicin—testicular cancer	0.000208	0.000613	CcSEcCtD
Sulfadiazine—Nausea—Epirubicin—testicular cancer	0.000197	0.000582	CcSEcCtD
Sulfadiazine—Vomiting—Doxorubicin—testicular cancer	0.000195	0.000576	CcSEcCtD
Sulfadiazine—Rash—Doxorubicin—testicular cancer	0.000194	0.000571	CcSEcCtD
Sulfadiazine—Dermatitis—Doxorubicin—testicular cancer	0.000193	0.000571	CcSEcCtD
Sulfadiazine—Headache—Doxorubicin—testicular cancer	0.000192	0.000568	CcSEcCtD
Sulfadiazine—Nausea—Doxorubicin—testicular cancer	0.000182	0.000538	CcSEcCtD
